Blood Pressure and Medication During Long-Term Antihypertensive Therapy Based on Morning Home SBP in Hypertensive Patients: Hypertension Control Based On Home Systolic Pressure (HOSP) Substudy

REFERENCES

• Ohkubo T, Imai Y, Tsuji I, Home blood pressure measurement has a stronger predictive power than dose screening blood pressure measurement: A population-based observation in Ohasama, Japan. J Hypertens 1998;16:971–975.
   PubMed Web of Science ®Google Scholar
• Tsunoda S, Kawano Y, Horio T, Okuda N, Takishita S. Relationship between home blood pressure and longitudinal changes in target organ damage in treated hypertensive patients. Hypertens Res 2002;25:167–173.
   PubMed Web of Science ®Google Scholar
• Bobrie G, Chatellier G, Genes N, Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004;291:1342–1349.
   PubMed Web of Science ®Google Scholar
• Sega R, Facchetti R, Bombelli M, Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: Follow-up results from the Pressioi Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005;111:1777–1783.
   PubMed Web of Science ®Google Scholar
• Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med 1993;153:598–615.
   PubMed Web of Science ®Google Scholar
• Psaty BM, Furberg CD, Kuller LH, Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality. Arch Intern Med 2001;161:1183–1192.
   PubMed Web of Science ®Google Scholar
• Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989;79:733–743.
   PubMed Web of Science ®Google Scholar
• Kario K, Pickering TG, Umeda Y, Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003;107:1401–1406.
   PubMed Web of Science ®Google Scholar
• Kawano Y, Mannami T, Saitoh D, Hypertension Control based on home systolic pressure (HOSP): Study design and interim report. J Hypertens 2002;20 (suppl 4):S162.
   Google Scholar
• Kawano Y, Mannami T, Saitoh D, Hypertension control based on home systolic pressure (HOSP) study: Design and interim report of the main study. J Hypertens 2006;20 (suppl 6):329.
   Google Scholar
• Kawano Y, Nakamura S, Horio T, Control of home blood pressure and urinary albumin excretion in patients with essential hypertension: HOSP substudy. Ther Res 2002;23: 790–793 (in Japanese).
   Google Scholar
• The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC): 2007 guidelines for the management of arterial hypertension. J Hypertens 2007;25:1105–1187.
   PubMed Web of Science ®Google Scholar
• Ogihara T, Kikuchi K, Matsuoka H, The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res 2009;32:3–107.
   PubMed Web of Science ®Google Scholar
• Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and United States. Arch Intern Med 2007;167:141–147.
   PubMed Web of Science ®Google Scholar
• Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension 2008;52:818–827.
   PubMed Web of Science ®Google Scholar
• Prospective studies collaboration: Age specific relevance of usual blood pressure to vascular mortality: A meta-analysis if individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903–1913.
   PubMed Web of Science ®Google Scholar
• Blood pressure lowering treatment trialists' collaboration: Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet 2004;352:1527–1535.
   Google Scholar
• Ohkubo T, Obara T, Funahashi J, Control of blood pressure as measured at home and office, and comparison with physicians' assessment of control among treated hypertensive patients in Japan: first report of the Japan Home versus Office Blood Pressure Measurement Rvaluation (J‐HOME) study. Hypertens Res 2004;27:755–763.
   PubMed Web of Science ®Google Scholar
• Kawano Y. Horio T, Matayoshi T, Kamide K. Masked hypertension: subtypes and target organ damage. Clin Exp Hypertens 2008;30:289–296.
   PubMed Web of Science ®Google Scholar
• Staessen JA, Den Hond E, Celis H, Antihypertensive treatment based on blood pressure measurement at home or in the physicians' office. JAMA 2004;291:955–964.
   PubMed Web of Science ®Google Scholar
• Cappuccio FP, Kerry SM, Forbes M, Donald A. Blood pressure control by home monitoring: mata-analysis of randomized trials. Br Med J 2004;329:145–148.
   PubMed Web of Science ®Google Scholar
• Fujiwara T, Nishimura T, Ohkubo T, Imai Y. Rationale and design of HOMED-BP study: Hypertension objective treatment based on measurement by electrical devices of blood pressure study. Blood Press Monit 2002;7:77–82.
   PubMed Web of Science ®Google Scholar
• Ohtawa H, Takayama F, Saitoh K, Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active angiotensin II receptor antagonist in humans. Br J Clin Pharmacol 1993;35:290–297.
   PubMed Web of Science ®Google Scholar
• Motomura S, Hashimoto K. Classification and pharmacokinetics of calcium antagonists. All about calcium antagonist. Saryta T, Hiwada K, Ogihara T, eds. Tokyo: Sentan Igaku Co., pp. 30–54, 1999.
   Google Scholar
• Nishimura T, Hashimoto J, Ohkubo T, Efficacy and duration of action of the four selective angiotensin II receptor blockers, losartan, candesartan, valsartan, and telmisartan, in patients with essential hypertension determined by home blood pressure measurements. Clin Exp Hypertens 2005;27:477–489.
   PubMed Web of Science ®Google Scholar
• Minami J, Ishimitsu T, Kawano Y, Matsuoka H. Effects of amlodipine and nifedipine retard on autonomic nerve activity in hypertensive patients. Clin Exp Pharmacol Physiol 1998;25: 572–576.
   PubMed Web of Science ®Google Scholar
• Iino Y, Hayashi M, Kawamura T, Renoprotective effect of losartan in comparison to amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for the Grobal Renal Protection in Hypertensive Patients (JLIGHT). Hypertens Res 2004;27:21–30.
   PubMed Web of Science ®Google Scholar